1. WHO Expert Committee on Drug Dependence, Delta-9-tetrahydrocannabinol. Critical Review, 2018.
2. Zuurman et al., Biomarkers for the effects of cannabis and THC in healthy volunteers. British Journal of Clinical Pharmacology, 2008.
3. Hall et al., What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis. Addictive Behaviors, 2020.
4. Mathew et al., Acute cannabis toxicity. Clinical toxicology, 2019.
5. Rigucci et al., Effects of high-potency cannabis on corpus callosum microstructure. Psychological Medicine, 2016.
6. Ravi et al., Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes. Annals of Internal Medicine, 2018.
7. Johnson-Sasso et al., Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction. PLoS ONE, 2018
8. Abuhasira et al., Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study. European Journal of Internal Medicine, 2021.
9. Hall, What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction, 2015.
10. Freeman & Winstock, Examining the proﬁle of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 2015.
11. Wall et al., Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity. Journal of Psychopharmacology, 2019.
12. D'Souza et al., Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis. The World Journal of Biological Psychiatry, 2022.
13. Hjorthøi et al., Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark. JAMA Psychiatry, 2021.)
14. Sami et al., Psychotic-like experiences with cannabis use predict cannabis cessation and desire to quit: a cannabis discontinuation hypothesis. Psychological Medicine, 2018
15. Di Forti et al., The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry, 2019.
16. Schreiner & Dunn, Residual Effects of Cannabis Use on Neurocognitive Performance After Prolonged Abstinence: A Meta-Analysis. Experimental and Clinical Psychopharmacology.
17. Schoeler et al., The effects of cannabis on memory function in users with and without a psychotic disorder: ﬁndings from a combined meta-analysis. Psychological Medicine, 2016.
18. Borque & Potvin, Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs. Frontiers in Psychiatry, 2021.
19. Daedelow et al., Are psychotic-like experiences related to a discontinuation of cannabis consumption in young adults? Schizophrenia Research, 2021.
20. Power et al., Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular Psychiatry, 2014.
21. Schaefer et al., Adolescent Cannabis Use and Adult Psychoticism: A Longitudinal Co-Twin Control Analysis Using Data From Two Cohorts. Journal of Abnormal Psychology, 2021.
22. Loweke et al., Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational Psychiatry, 2012.
23. Köck et al, Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study. Frontiers in Psychiatry, 2021.
24. Ksir & Hart, Cannabis and Psychosis: a Critical Overview of the Relationship.
25. Large et al., Cannabis Use and Earlier Onset of Psychosis A Systematic Meta-analysis. Arch. Gen. Psychiatry, 2011.
26. Scott et al., Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Psychiatry, 2018.
27. Meier et al, Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife. American Journal of Psychiatry, 2022.
28. Røgeberg O., Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status. PNAS, 2013.
29. Meier et al., Associations between Adolescent Cannabis Use and Neuropsychological Decline: A Longitudinal Co-Twin Control Study. Addiction, 2018.
30. Jackson et al., Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies. PNAS, 2016.
31. Kuc et al., Psychedelic experience dose‑dependently modulated by cannabis: results of a prospective online survey. Psychopharmacology, 2021.
32. Lukas & Orozco, Ethanol increases plasma D 9-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers. Drug and Alcohol Dependence, 2001.
33. Hartman et al., Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol. Clinical Chemistry, 2015.
34. Lukas et al., Marihuana attenuates the rise in plasma ethanol levels in human subjects. Neuropsychopharmacology, 1992.
35. Perez-Reyes & Cook, On the Marihuana Attenuation of the Rise of Ethanol Levels in Human Subjects. Neuropsychopharmacology, 1993.
36. Fisher et al., Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. International Journal of Drug Policy, 2022.
37. De Sousa Fernandes Perna et al., Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure. Psychopharmacology, 2016.
38. Myerscough, R. and S. Taylor, The effects of marijuana on human physical aggression. Journal of Pers Social Psychology, 1985.
39. Taylor, S.P., et al., The effects of alcohol and delta-9-tetrahydrocannabinol on human physical aggression. Aggressive Behavior, 1976.
40. Cherek, D.R., et al., Acute effects of marijuana smoking on aggressive, escape and point-maintained responding of male drug users. Psychopharmacology. 1993
41. Cherek, D.R. and D.M. Dougherty, Provocation frequency and its role in determining the effects of smoked marijuana on human aggressive responding. Behavioural Pharmacology, 1995.
42. Lehrer et al., Marijuana and Myocardial Infarction in the UK Biobank Cohort. Cureus, 2022.
43. Infante et al., Adolescent Brain Surface Area Pre- and Post-Cannabis and Alcohol Initiation. J Stud Alcohol Drugs, 2018.
44. Mahmood et al., Learning and Memory Performances in Adolescent Users of Alcohol and Marijuana: Interactive Effects. J stud Alcohol drugs, 2010.
45. Adejumo et al., Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease. Liver Int, 2018.
46. Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial
47. Impey et al., Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration. Pharmacology, Biochemistry & Behavior, 2015.
48. The Effects of Nicotine and Cannabis Co-Use during Adolescence and Young Adulthood on White Matter Cerebral Blood Flow Estimates
49. Agrawal et al., Simultaneous cannabis and tobacco use and cannabis-related outcomes in young women. Drug and Alcohol Dependence, 2009.
50. Weed et al., Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys. European Journal of Pharmacology, 2018.
51. Hattendorf et al., Interaction between delta(9)-tetrahydrocannabinol and d-amphetamine. Psychopharmacology, 1977.
52. Quigley & McCabe, The relationship between nicotine and psychosis. Therapeutic Advances in Psychopharmacology, 2019.
53. Chen et al., Brain cannabinoid receptor 2: expression, function and modulation. Acta Pharmacologica Sinica, 2017.
54. Murillo-Rodriguez et al., Cannabinoids and Neuropsychiatric Disorders. Advances in Experimental Medicine and Biology, 2019.
55. Huestis et al., Human Cannabinoid Pharmacokinetics. Chemistry & Biodiversity, 2007.
56. Verweij et al., A genetic perspective on the proposed inclusion of cannabis withdrawal in the DSM-5. Psychological Medicine, 2013.
57.Perisetti et al., Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology, 2020.
58. Drennan et al., Acute objective and subjective intoxication effects of legal‑market high potency THC‑dominant versus CBD‑dominant cannabis concentrates. Nature Scientific Reports, 2021.